Find Federal Grants
Bureau of Justice Assistance · O-BJA-2024-172230
STTR Solutions to Enable Population Genomic Screening (R41/R42 Clinical Trial Optional)
National Institutes of Health · PAR-24-262
National Institutes of Health · RFA-HD-25-003
Strengthening multisectoral global laboratory systems to safely and accurately mitigate biorisks, deploy diagnostics, and sequence pathogens to detect, prevent and respond to global health threats
Centers for Disease Control-GHC · CDC-RFA-JG-25-0162
Centers for Disease Control-GHC · CDC-RFA-JG-25-0154
Centers for Disease Control-GHC · CDC-RFA-JG-25-0152
Centers for Disease Control-GHC · CDC-RFA-JG-25-0151
Strengthen national and sub-national capacities to implement the International Health Regulations through local partners in Nigeria
Centers for Disease Control-GHC · CDC-RFA-JG-25-0146
Protecting and Improving Public Health Globally: Building and Strengthening Public Health Impact, Health Systems, Capacity Building, and Health Security in Mali
Centers for Disease Control-GHC · CDC-RFA-JG-25-0145
Continuing to enhance Global Health Security by sustaining efforts and strategies to protect and improve public health in Kenya
Centers for Disease Control-GHC · CDC-RFA-JG-25-0143
Centers for Disease Control-GHC · CDC-RFA-JG-25-0141
Advancing Ethiopia’s capacity to meet the International Health Regulations through local partner engagement
Centers for Disease Control-GHC · CDC-RFA-JG-25-0139
The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional)
National Institutes of Health · RFA-CA-25-012
The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-25-011
Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Between Sex Hormones, HIV, and Addictive Substances (R21 Clinical Trials Not Allowed)
National Institutes of Health · RFA-DA-26-008
Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Between Sex Hormones, HIV, and Addictive Substances (R01 Clinical Trials Not Allowed)
National Institutes of Health · RFA-DA-26-007
Center for Medicare and Medicaid Services · CMS-2P2-25-001
Service Area Competition
Health Resources and Services Administration · HRSA-25-016
Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional)
National Institutes of Health · RFA-HG-24-023
Population Genomic Screening in Primary Care Coordinating Center(U01 -Clinical Trials Optional)
National Institutes of Health · RFA-HG-24-022